Clinical Trials Browser

Phase 2 × pemigatinib × Sarcoma × Clear all

NCT07434843 2026-02-27

PEMIGIST

Phase 2 Not yet recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06551896 2024-08-13

Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor

Phase 2 Not yet recruiting

BreastGastrointestinalGenitourinarySarcomaThoracic

Breast Neoplasms, Carcinoma, Carcinoma, Transitional Cell, Lung Neoplasms, Sarcoma, Stomach Neoplasms